https://www.integralmolecular.com/integral-molecular-awarded-9-1-million-contract-from-niaid-to-map-epitopes-on-viral-pathogens-using-shotgun-mutagenesis-mapping-technology/ 2017-10-03T12:15:28+00:00 https://www.integralmolecular.com/integral-molecular-announces-key-patent-issued-on-lipoparticle-technology-for-deriving-high-concentrations-of-cell-free-membrane-proteins/ 2017-10-03T12:15:53+00:00 https://www.integralmolecular.com/integral-molecular-to-expand-its-headquarters-at-the-science-center-in-philadelphia/ 2017-10-03T12:16:15+00:00 https://www.integralmolecular.com/integral-molecular-announces-lipoparticle-distribution-in-japan-by-funakoshi/ 2017-10-03T12:16:36+00:00 https://www.integralmolecular.com/integral-molecular-announces-patent-allowance-for-its-membrane-protein-lipoparticle-technology/ 2017-10-03T12:17:01+00:00 https://www.integralmolecular.com/integral-molecular-and-crystal-bioscience-announce-research-collaboration-to-develop-novel-gpcr-and-ion-channel-antibodies/ 2017-10-03T12:17:19+00:00 https://www.integralmolecular.com/integral-molecular-and-intellicyt-corporation-announce-co-marketing-collaboration/ 2017-10-03T12:17:45+00:00 https://www.integralmolecular.com/patent-for-nano-scale-detection-of-ion-channel-function-in-lipoparticles/ 2017-10-03T12:18:12+00:00 https://www.integralmolecular.com/integral-molecular-launches-mps-platform-for-discovery-of-antibodies-targeting-membrane-proteins/ 2017-10-03T12:18:29+00:00 https://www.integralmolecular.com/integral-molecular-announces-issuance-of-third-patent-family-extending-patent-landscape-for-key-lipoparticle-technology/ 2017-10-03T12:18:44+00:00 https://www.integralmolecular.com/integral-molecular-develops-b-cell-cloning-technology-to-discover-rare-antibodies-against-membrane-proteins/ 2017-10-03T12:25:05+00:00 https://www.integralmolecular.com/integral-molecular-announces-patent-allowance-for-dengue-research-technology/ 2017-12-13T13:12:15+00:00 https://www.integralmolecular.com/integral-molecular-enters-immuno-oncology-target-discovery-collaboration-with-daiichi-sankyo/ 2019-01-07T15:02:06+00:00 https://www.integralmolecular.com/integral-moleculars-therapeutic-mabs-against-cb1-to-treat-nash-enter-new-development-phase-following-1-4m-nih-award/ 2019-01-09T17:33:11+00:00 https://www.integralmolecular.com/integral-molecular-awarded-nih-grant-to-discover-neuroimmune-drug-targets-in-alzheimers-disease/ 2019-01-09T17:34:23+00:00 https://www.integralmolecular.com/integral-molecular-celebrates-epitope-mapping-milestone-of-1000-epitopes/ 2019-01-09T17:39:42+00:00 https://www.integralmolecular.com/integral-moleculars-mps-antibody-discovery-platform-yields-therapeutic-assets-for-oncology-and-metabolic-syndrome/ 2019-01-09T17:43:12+00:00 https://www.integralmolecular.com/integral-molecular-expands-epitope-mapping-platform-identify-small-molecule-binding-sites-multipass-membrane-proteins/ 2019-01-09T17:49:16+00:00 https://www.integralmolecular.com/integral-moleculars-protein-engineering-technology-facilitates-hiv-vaccine-development/ 2019-01-09T17:50:13+00:00 https://www.integralmolecular.com/integral-molecular-hosts-art-of-science-residency/ 2019-01-09T17:52:14+00:00 https://www.integralmolecular.com/integral-molecular-doubles-antibody-discovery-capacity/ 2019-01-09T17:53:57+00:00 https://www.integralmolecular.com/integral-molecular-announces-technology-advancement-for-discovery-of-new-immuno-oncology-therapeutic-targets/ 2019-01-09T17:54:42+00:00 https://www.integralmolecular.com/immunization-elicited-antibody-shows-universal-protection-against-multiple-ebolaviruses/ 2019-01-09T17:57:12+00:00 https://www.integralmolecular.com/integral-molecular-and-integrated-biotherapeutics-initiate-collaboration-for-virus-vaccine-discovery/ 2019-01-09T17:58:04+00:00 https://www.integralmolecular.com/integral-molecular-isolates-zika-specific-monoclonal-antibodies-for-vaccine-research-and-diagnostics/ 2019-01-09T17:59:14+00:00 https://www.integralmolecular.com/antibody-protects-against-fetal-disease-in-mouse-model-of-zika-infection/ 2019-01-09T18:01:13+00:00 https://www.integralmolecular.com/integral-molecular-launches-target-specificity-technology-to-improve-safety-of-biotherapeutics/ 2019-01-09T18:02:24+00:00 https://www.integralmolecular.com/integral-molecular-announces-breakthrough-in-understanding-the-functionality-of-gpcrs-the-largest-class-of-drug-targets-in-human-disease/ 2019-01-09T18:03:23+00:00 https://www.integralmolecular.com/integral-molecular-expands-intellectual-property-landscape-with-international-patents-protecting-key-lipoparticle-technology/ 2019-01-09T18:04:35+00:00 https://www.integralmolecular.com/dna-immunization-expert-dr-ross-chambers-joins-integral-molecular-to-lead-antibody-discovery/ 2019-01-09T18:05:04+00:00 https://www.integralmolecular.com/integral-molecular-identifies-key-molecular-interactions-responsible-for-the-effectiveness-of-the-zmapp-anti-ebola-virus-cocktail/ 2019-01-09T18:05:56+00:00 https://www.integralmolecular.com/integral-molecular-awarded-5-5m-by-the-national-institutes-of-health-to-study-ebola-antibodies-to-aid-in-vaccine-discovery/ 2019-01-09T18:06:46+00:00 https://www.integralmolecular.com/cat-got-your-tongue-not-according-to-new-research/ 2019-01-09T18:07:28+00:00 https://www.integralmolecular.com/integral-molecular-identifies-potent-inhibitory-antibodies-against-chikungunya-virus/ 2019-01-09T18:08:02+00:00 https://www.integralmolecular.com/integral-molecular-awarded-3-5m-contract-from-nih-to-study-ebola-and-hepatitis-c-virus-antibody-response/ 2019-01-09T18:08:48+00:00 https://www.integralmolecular.com/integral-molecular-announces-patent-protecting-the-use-of-lipoparticles-for-antibody-discovery/ 2019-01-09T18:09:43+00:00 https://www.integralmolecular.com/integral-molecular-identifies-potent-antibody-antagonists-against-ion-channel-pain-target-p2x3/ 2019-01-09T18:10:24+00:00 https://www.integralmolecular.com/integral-molecular-to-present-claudin-6-mabs-a-therapeutic-asset-for-solid-tumors-at-annual-aacr-conference/ 2019-04-16T12:53:44+00:00 https://www.integralmolecular.com/integral-molecular-doubles-antibody-characterization-capacity-within-philadelphias-science-center/ 2019-04-16T13:21:29+00:00 https://www.integralmolecular.com/integral-molecular-reaches-milestone-in-immuno-oncology-target-discovery-collaboration-with-daiichi-sankyo/ 2019-05-28T16:39:51+00:00 https://www.integralmolecular.com/integral-molecular-and-penn-medicine-collaborate-on-autoimmune-encephalitis-target-discovery/ 2019-08-08T18:31:27+00:00 https://www.integralmolecular.com/integral-molecular-selected-as-the-first-industry-partner-in-the-wistar-institutes-biomedical-research-technician-apprenticeship/ 2019-09-26T18:47:55+00:00 https://www.integralmolecular.com/philadelphias-integral-molecular-opens-new-research-center-in-response-to-upsurge-in-antibody-discovery-partnerships/ 2019-10-18T13:07:47+00:00 https://www.integralmolecular.com/integral-molecular-to-advance-vaccine-discovery-with-nih-contract-for-5-5m/ 2019-12-10T15:49:37+00:00 https://www.integralmolecular.com/integral-molecular-announces-preclinical-p2x7-antibody-assets-for-autoimmune-disorders/ 2020-01-09T15:27:43+00:00 https://www.integralmolecular.com/integral-molecular-launches-readymap-services-for-rapid-conformational-epitope-mapping/ 2020-02-12T20:23:14+00:00 https://www.integralmolecular.com/integral-molecular-accelerates-coronavirus-vaccine-research/ 2020-03-09T13:51:15+00:00 https://www.integralmolecular.com/integral-molecular-announces-the-expansion-of-its-membrane-proteome-array-technology-for-improving-antibody-safety-and-new-target-discovery/ 2020-03-12T15:34:17+00:00 https://www.integralmolecular.com/integral-molecular-receives-niaid-award-to-combat-covid-19/ 2020-04-21T14:37:55+00:00 https://www.integralmolecular.com/integral-molecular-develops-test-for-neutralizing-antibodies-in-covid-19-patients-and-clinical-trials/ 2020-04-30T15:21:41+00:00 https://www.integralmolecular.com/integral-molecular-provides-rapid-safety-testing-of-covid-19-antibody-therapeutics-with-its-membrane-proteome-array-technology/ 2020-06-10T14:51:19+00:00 https://www.integralmolecular.com/integral-molecular-expands-its-reporter-virus-technology-to-enable-broad-testing-for-coronavirus-protection-against-emerging-strains-including-d614g/ 2020-07-13T15:54:27+00:00 https://www.integralmolecular.com/science-center-to-honor-leaders-of-innovation-community-at-annual-nucleus-awards/ 2020-09-03T15:39:42+00:00 https://www.integralmolecular.com/wp-content/uploads/2020/08/BenNucAWard.png https://www.integralmolecular.com/humanized-chicken-antibody-technology-to-drive-next-generation-of-integral-moleculars-mps-antibody-discovery-platform/ 2020-09-10T14:23:47+00:00 https://www.integralmolecular.com/integral-molecular-awarded-grant-from-the-commonwealth-of-pennsylvania-to-advance-covid-19-research/ 2020-09-18T18:18:06+00:00 https://www.integralmolecular.com/totient-leverages-integral-moleculars-membrane-proteome-array-to-advance-cancer-therapeutic-discovery/ 2020-10-14T14:10:31+00:00 https://www.integralmolecular.com/wp-content/uploads/2020/10/Totient_Title_IG_post_Compressed.png https://www.integralmolecular.com/integral-molecular-partners-with-chinas-leading-preclinical-cro-joinn-for-comprehensive-specificity-testing-of-antibodies-and-car-t-therapeutics/ 2020-11-19T16:43:29+00:00 https://www.integralmolecular.com/integral-molecular-announces-best-in-class-antibodies-against-complex-oncology-target-claudin-18-2/ 2020-11-24T14:48:57+00:00 https://www.integralmolecular.com/immunization-elicited-broadly-protective-antibody-reveals-ebolavirus-fusion-loop-as-a-site-of-vulnerability/ 2021-01-07T16:37:11+00:00 https://www.integralmolecular.com/cooperativity-enables-non-neutralizing-antibodies-to-neutralize-ebolavirus/ 2021-01-07T16:37:11+00:00 https://www.integralmolecular.com/mapping-the-human-memory-b-cell-and-serum-neutralizing-antibody-responses-to-dengue-virus-serotype-4-infection-and-vaccination/ 2021-01-07T16:37:11+00:00 https://www.integralmolecular.com/neutralizing-human-antibodies-prevent-zika-virus-replication-and-fetal-disease-in-mice/ 2021-01-07T16:37:11+00:00 https://www.integralmolecular.com/lower-igg-somatic-hypermutation-rates-during-acute-dengue-virus-infection-is-compatible-with-a-germinal-center-independent-b-cell-response/ 2021-01-07T16:37:11+00:00 https://www.integralmolecular.com/dna-immunization-combined-with-scfv-phage-display-identifies-antagonistic-gcgr-specific-antibodies-and-reveals-new-epitopes-on-the-small-extracellular-loops/ 2021-01-07T16:37:12+00:00 https://www.integralmolecular.com/rapid-isolation-of-dengue-neutralizing-antibodies-from-single-cell-sorted-human-antigen-specific-memory-b-cell-cultures/ 2021-01-07T16:37:12+00:00 https://www.integralmolecular.com/neutralizing-monoclonal-antibodies-block-chikungunya-virus-entry-and-release-by-targeting-an-epitope-critical-to-viral-pathogenesis/ 2021-01-07T16:37:13+00:00 https://www.integralmolecular.com/integral-molecular-sizes-up-ebolamembrane-protein-specialist-maps-ebolas-binding-sites-to-advance-vaccine-discovery/ 2021-01-07T16:37:13+00:00 https://www.integralmolecular.com/broadly-neutralizing-alphavirus-antibodies-bind-an-epitope-on-e2-and-inhibit-entry-and-egress/ 2021-01-07T16:37:13+00:00 https://www.integralmolecular.com/cryo-em-structures-elucidate-neutralizing-mechanisms-of-anti-chikungunya-human-monoclonal-antibodies-with-therapeutic-activity/ 2021-01-07T16:37:13+00:00 https://www.integralmolecular.com/isolation-and-characterization-of-broad-and-ultrapotent-human-monoclonal-antibodies-with-therapeutic-activity-against-chikungunya-virus/ 2021-01-07T16:37:13+00:00 https://www.integralmolecular.com/potent-and-efficacious-inhibition-of-cxcr2-signaling-by-biparatopic-nanobodies-combining-two-distinct-modes-of-action/ 2021-01-07T16:37:13+00:00 https://www.integralmolecular.com/hcv-e2-core-structures-and-mabs-something-is-still-missing/ 2021-01-07T16:37:13+00:00 https://www.integralmolecular.com/membrane-protein-solutions-for-antibody-discovery/ 2021-01-07T16:37:13+00:00 https://www.integralmolecular.com/atomic-level-functional-model-of-dengue-virus-envelope-protein-infectivity/ 2021-01-07T16:37:13+00:00 https://www.integralmolecular.com/functional-analysis-of-antibodies-against-dengue-virus-type-4-reveals-strain-dependent-epitope-exposure-that-impacts-neutralization-and-protection/ 2021-01-07T16:37:15+00:00 https://www.integralmolecular.com/isolating-membrane-protein-antibodies/ 2021-01-07T16:37:15+00:00 https://www.integralmolecular.com/dengue-reporter-virus-particles-for-measuring-neutralizing-antibodies-against-each-of-the-four-dengue-serotypes/ 2021-01-07T16:37:15+00:00 https://www.integralmolecular.com/maximal-humanization-of-monoclonal-abs/ 2021-01-07T16:37:15+00:00 https://www.integralmolecular.com/antibodies-against-membrane-protein-targets/ 2021-01-07T16:37:15+00:00 https://www.integralmolecular.com/mapping-complex-antibody-epitopes/ 2021-01-07T16:37:15+00:00 https://www.integralmolecular.com/antibody-strategies-for-membrane-protein-targets/ 2021-01-07T16:37:15+00:00 https://www.integralmolecular.com/epitope-mapping-in-antibody-therapeutics-and-vaccine-development-the-evolving-landscape/ 2021-01-07T16:37:16+00:00 https://www.integralmolecular.com/new-approaches-for-mab-discovery/ 2021-01-07T16:37:16+00:00 https://www.integralmolecular.com/kinetic-analysis-of-membrane-protein-interactions-using-optical-biosensor/ 2021-01-07T16:37:17+00:00 https://www.integralmolecular.com/elicitation-monoclonal-antibodies-using-lipoparticles/ 2021-01-07T16:37:17+00:00 https://www.integralmolecular.com/lipoparticle-purity-and-stability/ 2021-01-07T16:37:17+00:00 https://www.integralmolecular.com/fluorescent-biotin-modified-lipoparticles/ 2021-01-07T16:37:17+00:00 https://www.integralmolecular.com/mapping-functional-regions-gpcrs-using-shotgun-mutagenesis/ 2021-01-07T16:37:17+00:00 https://www.integralmolecular.com/protecting-antibody-intellectual-property-epitope-mapping/ 2021-01-07T16:37:17+00:00 https://www.integralmolecular.com/mapping-docking-gpcr-drug-interactions-using-shotgun-mutagenesis/ 2021-01-07T16:37:17+00:00 https://www.integralmolecular.com/atomic-level-mapping-antibody-epitopes-shotgun-mutagenesis/ 2021-01-07T16:37:17+00:00 https://www.integralmolecular.com/dengue-reporter-virus-stability/ 2021-01-07T16:37:18+00:00 https://www.integralmolecular.com/detailed-antibody-characterization-enabled-high-throughput-flow-cytometery/ 2021-01-07T16:37:18+00:00 https://www.integralmolecular.com/lipoparticles/ 2021-01-07T16:37:18+00:00 https://www.integralmolecular.com/lipoparticles-2/ 2021-01-07T16:37:18+00:00 https://www.integralmolecular.com/mps-antibody-discovery/ 2021-01-07T16:37:18+00:00 https://www.integralmolecular.com/epitope-mapping/ 2021-01-07T16:37:18+00:00 https://www.integralmolecular.com/mps-antibody-discovery-2/ 2021-01-07T16:37:18+00:00 https://www.integralmolecular.com/mps-antibody-discovery-3/ 2021-01-07T16:37:18+00:00 https://www.integralmolecular.com/membrane-proteome-array/ 2021-01-07T16:37:18+00:00 https://www.integralmolecular.com/mps-antibody-discovery-cb1-case-study/ 2021-01-07T16:37:19+00:00 https://www.integralmolecular.com/high-throughput-protein-engineering-improves-antigenicity-stability-soluble-hiv-1-envelope-glycoprotein-sosip-trimers/ 2021-01-07T16:37:19+00:00 https://www.integralmolecular.com/probing-antigenicity-hepatitis-c-virus-envelope-glycoprotein-complex-high-throughput-mutagenesis/ 2021-01-07T16:37:19+00:00 https://www.integralmolecular.com/mab-discovery-membrane-proteins/ 2021-01-07T16:37:20+00:00 https://www.integralmolecular.com/broadly-neutralizing-antibodies-from-human-survivors-target-a-conserved-site-in-the-ebola-virus-glycoprotein-hr2-mper-region/ 2021-01-07T16:37:20+00:00 https://www.integralmolecular.com/systematic-analysis-of-monoclonal-antibodies-against-ebola-virus-gp-defines-features-that-contribute-to-protection/ 2021-01-07T16:37:20+00:00 https://www.integralmolecular.com/structural-basis-of-a-potent-human-monoclonal-antibody-against-zika-virus-targeting-a-quaternary-epitope/ 2021-01-07T16:37:20+00:00 https://www.integralmolecular.com/optimal-therapeutic-activity-of-monoclonal-antibodies-against-chikungunya-virus-requires-fc-fc%ce%b3r-interaction-on-monocytes/ 2021-01-07T16:37:20+00:00 https://www.integralmolecular.com/lipoparticles-case-cx3cr1-case-study/ 2021-01-07T16:37:21+00:00 https://www.integralmolecular.com/the-science-of-sars-cov-2-what-do-we-know-what-are-we-doing/ 2021-01-07T16:37:22+00:00 https://www.integralmolecular.com/sars-cov-2-reporter-virus-neutralization-assays/ 2021-01-07T16:37:22+00:00 https://www.integralmolecular.com/transcriptional-and-clonal-characterization-of-b-cell-plasmablast-diversity-following-primary-and-secondary-natural-denv-infection/ 2021-01-07T16:37:22+00:00 https://www.integralmolecular.com/integral-molecular-enables-rapid-resistance-testing-of-vaccines-and-drugs-against-emerging-coronavirus-variants/ 2021-02-04T22:13:01+00:00 https://www.integralmolecular.com/sars-cov-2-reporter-virus-particles/ 2021-05-03T16:04:36+00:00 https://www.integralmolecular.com/integrated-pipeline-for-the-accelerated-discovery-of-antiviral-antibody-therapeutics/ 2021-05-13T14:35:17+00:00 https://www.integralmolecular.com/brain-specific-angiogenesis-inhibitor-1-is-expressed-in-the-myo-nog-cell-lineage/ 2021-05-13T14:36:52+00:00 https://www.integralmolecular.com/neutralizing-and-protective-human-monoclonal-antibodies-recognizing-the-n-terminal-domain-of-the-sars-cov-2-spike-protein/ 2021-05-13T16:40:01+00:00 https://www.integralmolecular.com/antigenicity-stability-and-reproducibility-of-zika-reporter-virus-particles-for-long-term-applications/ 2021-05-13T16:45:44+00:00 https://www.integralmolecular.com/a-novel-antigenic-site-spanning-domains-i-and-iii-of-the-zika-virus-envelope-glycoprotein-is-the-target-of-strongly-neutralizing-human-monoclonal-antibodies/ 2021-05-13T16:47:28+00:00 https://www.integralmolecular.com/integral-molecular-expands-partnership-with-japans-life-sciences-distributor-funakoshi-to-provide-access-to-antibody-specificity-and-epitope-mapping-services/ 2021-06-08T12:00:06+00:00 https://www.integralmolecular.com/integral-moleculars-rapid-sars-cov-2-epitope-mapping-supports-regulatory-requirements-for-the-development-of-therapeutic-antibodies-effective-against-viral-variants/ 2021-06-15T13:35:51+00:00 https://www.integralmolecular.com/integral-molecular-launches-transgene-protein-engineering-platform-to-address-challenges-in-gene-therapy/ 2021-08-03T14:55:28+00:00 https://www.integralmolecular.com/the-science-centers-esther-klein-gallery-reopens-with-exhibit-exploring-the-effects-of-sars-cov-2-and-covid-19/ 2021-08-04T19:15:58+00:00 https://www.integralmolecular.com/wp-content/uploads/2021/08/sociuspostcard-frontsocial.jpg https://www.integralmolecular.com/integral-moleculars-extensive-collection-of-sars-cov-2-reporter-virus-variants-supports-the-clinical-development-of-vaccines-and-mabs-against-coronavirus/ 2021-08-18T11:09:28+00:00 https://www.integralmolecular.com/sars-cov-2-rvps-and-live-virus-show-similar-neutralization-titers/ 2021-08-17T19:49:41+00:00 https://www.integralmolecular.com/philadelphia-biotech-integral-molecular-celebrates-20-years-of-innovation-growth-and-community/ 2021-10-12T11:07:14+00:00 https://www.integralmolecular.com/wp-content/uploads/2021/10/INTG-leadership-team-with-Mayor-scaled.jpeg https://www.integralmolecular.com/wp-content/uploads/2021/10/INTG-leadership-team-with-Mayor-scaled.jpeg https://www.integralmolecular.com/integral-molecular-and-integrated-biotherapeutics-collaborate-to-engineer-broadly-protective-ebolavirus-vaccines/ 2021-11-02T13:15:30+00:00 https://www.integralmolecular.com/integral-molecular-adds-omicron-to-its-panel-of-68-sars-cov-2-reporter-virus-variants-to-assess-the-effectiveness-of-vaccines-and-therapeutics/ 2021-12-07T15:02:33+00:00 https://www.integralmolecular.com/integral-molecular-adds-transgenic-humanized-mice-to-expand-antibody-discovery-platform/ 2022-01-05T13:45:22+00:00 https://www.integralmolecular.com/lipoparticle-technology/ 2022-02-24T16:34:42+00:00 https://www.integralmolecular.com/integral-molecular-partners-with-philadelphia-fight-medical-clinic-to-support-community-health/ 2022-03-08T14:22:53+00:00 https://www.integralmolecular.com/wp-content/uploads/2022/03/FIGHT-INTG-1024x611.jpg https://www.integralmolecular.com/wp-content/uploads/2022/03/FIGHT-CROP-272x300.jpg https://www.integralmolecular.com/lonza-early-development-services-and-integral-molecular-to-offer-complementary-expertise-to-enhance-early-de-risking-of-biotherapeutics/ 2022-04-25T12:58:18+00:00 https://www.integralmolecular.com/integral-molecular-breaks-ground-on-new-headquarters-doubling-in-size/ 2022-05-24T11:23:08+00:00 https://www.integralmolecular.com/wp-content/uploads/2022/05/construction-pic-adjusted-color.jpg https://www.integralmolecular.com/wp-content/uploads/2022/05/construction-pic-adjusted-color.jpg https://www.integralmolecular.com/pfaff-kilgore-and-colleagues-describe-a-comprehensive-mutagenesis-and-functional-study-of-the-e1e2-protein-of-hepatitis-c-virus-in-cell-reports/ 2022-06-01T19:38:56+00:00 https://www.integralmolecular.com/wp-content/uploads/2022/05/Untitled-design-12.png https://www.integralmolecular.com/wp-content/uploads/2022/05/cell-reports.png https://www.integralmolecular.com/integral-molecular-and-optimeos-life-sciences-enter-partnership-to-develop-mrna-and-dna-based-gene-therapies-using-molecular-targeting/ 2022-06-08T13:42:08+00:00 https://www.integralmolecular.com/integral-molecular-webinar-user-group-towards-ind-specificity-profiling-of-antibody-therapies-using-the-membrane-proteome-array/ 2022-09-07T19:20:57+00:00 https://www.integralmolecular.com/live-tutorial-6-steps-to-success-in-discovering-monoclonal-antibodies-against-multipass-membrane-proteins/ 2022-09-07T19:30:50+00:00 https://www.integralmolecular.com/wp-content/uploads/2020/10/News-Featur-Image-1.png https://www.integralmolecular.com/integral-molecular-fierce-bio-present-de-risk-antibody-and-car-t-safety-by-identifying-off-target-specificity-webinar/ 2022-09-07T19:37:34+00:00 https://www.integralmolecular.com/wp-content/uploads/2020/09/BlogFIerceBio.png https://www.integralmolecular.com/fda-announcement-cder-and-cber-accept-first-submission-to-istand-pilot-program/ 2022-09-08T20:04:35+00:00 https://www.integralmolecular.com/fda-accepts-integral-moleculars-letter-of-intent-loi-on-membrane-proteome-array-antibody-specificity-test-into-istand-drug-development-tools-pilot-program/ 2023-03-03T16:18:29+00:00 https://www.integralmolecular.com/genetic-engineering-and-integral-molecular-present-reporter-virus-tools-to-combat-current-viral-threats-and-the-next-pandemic/ 2023-04-04T13:53:18+00:00 https://www.integralmolecular.com/wp-content/uploads/2022/10/GEN-Nov-2022-Speakers.png https://www.integralmolecular.com/genetic-engineering-and-integral-molecular-present-towards-ind-specificity-profiling-of-antibody-based-therapies/ 2023-04-04T13:54:41+00:00 https://www.integralmolecular.com/wp-content/uploads/2022/07/Copy-of-GEN-Webinar-Social-714-1024-%C3%97-325-px-4.png https://www.integralmolecular.com/rvp-users-group-omicron-rvps-and-their-role-in-safe-neutralization-assessment-february-15th-11am-et/ 2023-04-04T13:57:06+00:00 https://www.integralmolecular.com/wp-content/uploads/2022/01/MicrosoftTeams-image-13.png https://www.integralmolecular.com/wp-content/uploads/2022/01/MicrosoftTeams-image-14.png https://www.integralmolecular.com/webinar-combatting-sars-cov-2-variants-neutralization-testing-from-alpha-to-mu/ 2023-04-04T13:58:15+00:00 https://www.integralmolecular.com/webinar-comprehensive-specificity-profiling-of-antibody-based-therapeutics-using-the-membrane-proteome-array/ 2023-04-04T13:58:53+00:00 https://www.integralmolecular.com/integral-molecular-opens-new-research-center/ 2023-04-28T14:28:12+00:00 https://www.integralmolecular.com/wp-content/uploads/2023/04/Ribbon-cutting-uCity-Square-scaled.jpg https://www.integralmolecular.com/wp-content/uploads/2023/04/Ribbon-cutting-uCity-Square-scaled.jpg https://www.integralmolecular.com/commonwealth-of-pa-awards-integral-molecular-one-million/ 2023-06-21T15:08:59+00:00 https://www.integralmolecular.com/wp-content/uploads/2023/06/Group-photo-in-lab-scaled.jpg https://www.integralmolecular.com/wp-content/uploads/2023/06/Group-photo-in-lab-scaled.jpg https://www.integralmolecular.com/integral-molecular-announces-antibody-discovery-collaboration-with-ono-pharmaceutical/ 2024-04-19T16:18:25+00:00 https://www.integralmolecular.com/integral-molecular-partners-with-merus-to-discover-novel-therapeutic-monoclonal-antibodies/ 2024-04-19T16:20:11+00:00 https://www.integralmolecular.com/context-therapeutics-and-integral-molecular-enter-license-deal-for-novel-claudin-6-antibodies/ 2024-04-23T20:08:47+00:00 https://www.integralmolecular.com/wp-content/uploads/2021/04/Context-1.png https://www.integralmolecular.com/integral-molecular-enters-antibody-license-agreement-with-astrazeneca/ 2024-04-23T20:14:01+00:00 https://www.integralmolecular.com/integral-molecular-licenses-claudin-18-2-monoclonal-antibodies-to-cartexell/ 2024-04-23T20:20:02+00:00 https://www.integralmolecular.com/integral-molecular-presents-data-on-monoclonal-antibodies-mabs-against-slc2a4-glut4-a-critical-target-for-diabetes/ 2024-06-04T19:43:41+00:00 https://www.integralmolecular.com/city-of-philadelphia-recognized-integral-molecular-as-employer-of-choice/ 2025-01-16T16:36:30+00:00 https://www.integralmolecular.com/wp-content/uploads/2025/01/54263091742_d38f83ec03_c.jpg https://www.integralmolecular.com/wp-content/uploads/2025/01/54263091742_d38f83ec03_c.jpg https://www.integralmolecular.com/out-licensed-bispecific-antibody-enters-clinical-trial-for-treating-solid-tumors/ 2025-04-28T17:34:21+00:00 https://www.integralmolecular.com/wp-content/uploads/2025/03/News-Page-Featured-Images-1.png https://www.integralmolecular.com/webinar-presented-by-integral-molecular-and-antibody-society-how-specific-are-antibody-drugs/ 2025-04-28T17:43:08+00:00 https://www.integralmolecular.com/wp-content/uploads/2025/01/Promo-Banner-Antibody-Soc-2025-1-1.png https://www.integralmolecular.com/wp-content/uploads/2025/01/Promo-Banner-Antibody-Soc-2025-1.png https://www.integralmolecular.com/integral-molecular-awarded-2-million-to-advance-the-mpa-towards-fda-qualification/ 2025-04-28T17:46:45+00:00 https://www.integralmolecular.com/wp-content/uploads/2024/11/Integral-Molecular-May-2024-47-1-scaled.jpg https://www.integralmolecular.com/integral-molecular-secures-niaid-contract-to-combat-emerging-viruses/ 2025-04-28T17:50:54+00:00 https://www.integralmolecular.com/wp-content/uploads/2024/10/News-Page-Featured-Images-2.png https://www.integralmolecular.com/cell-surface-bio-set-to-transform-the-antibody-reagent-market/ 2025-04-28T17:52:30+00:00 https://www.integralmolecular.com/wp-content/uploads/2024/05/CSB-press-release-image-May-2024.jpg https://www.integralmolecular.com/wp-content/uploads/2024/05/CSB-press-release-image-May-2024.jpg https://www.integralmolecular.com/webinar-presented-by-integral-molecular-redefining-antibody-specificity-profiling-for-ind/ 2025-04-28T17:54:05+00:00 https://www.integralmolecular.com/wp-content/uploads/2024/04/MPA-Fierce-Webinar-2024-Email-6.png https://www.integralmolecular.com/wp-content/uploads/2024/04/MPA-Fierce-Webinar-2024-Email-6.png https://www.integralmolecular.com/webinar-presented-by-integral-molecular-and-the-antibody-society/ 2025-04-28T17:56:18+00:00 https://www.integralmolecular.com/wp-content/uploads/2024/04/Headers-Antibody-Soc.png https://www.integralmolecular.com/wp-content/uploads/2024/04/Headers-Antibody-Soc.png https://www.integralmolecular.com/integral-molecular-enters-into-antibody-license-with-seismic-therapeutic/ 2025-04-28T17:57:53+00:00 https://www.integralmolecular.com/wp-content/uploads/2024/04/Untitled-design-17.png https://www.integralmolecular.com/integral-molecular-secures-nearly-900k-in-nih-funding/ 2025-04-28T18:11:03+00:00 https://www.integralmolecular.com/wp-content/uploads/2024/10/News-Page-Featured-Images-2.png https://www.integralmolecular.com/integral-molecular-webinar-conquering-undruggable-targets-to-obtain-preclinical-antibodies/ 2025-04-28T18:14:16+00:00 https://www.integralmolecular.com/wp-content/uploads/2023/07/Speaker-Header-Graphic.png https://www.integralmolecular.com/wp-content/uploads/2023/07/Speaker-Header-Graphic.png https://www.integralmolecular.com/mpa-specificity-testing-gen-webinar/ 2025-04-28T18:37:11+00:00 https://www.integralmolecular.com/wp-content/uploads/2023/05/GEN-June-2023-Speakers-6.png https://www.integralmolecular.com/wp-content/uploads/2023/05/GEN-June-2023-Speakers-6.png https://www.integralmolecular.com/integral-molecular-reveals-mechanism-underlying-exquisite-specificity-of-claudin-6-therapeutic-antibody-being-developed-for-solid-tumors/ 2025-04-28T18:38:51+00:00 https://www.integralmolecular.com/integral-molecular-launches-titersafe-influenza-virus-like-particles/ 2025-04-28T18:47:33+00:00 https://www.integralmolecular.com/wp-content/uploads/2023/11/TiterSafeTM-a-safe-substitute-for-live-virus-in-HAI-assays-3.png https://www.integralmolecular.com/wp-content/uploads/2023/11/TiterSafe-e1703691737231.png https://www.integralmolecular.com/integral-molecular-launches-virus-neutralization-assay-services/ 2025-04-28T18:49:26+00:00 https://www.integralmolecular.com/wp-content/uploads/2024/04/Integral-Molecular-May-2024-70-scaled.jpg https://www.integralmolecular.com/webinar-presented-by-integral-molecular-mobilizing-safe-research-tools-for-pandemic-preparedness/ 2025-04-28T18:49:50+00:00 https://www.integralmolecular.com/wp-content/uploads/2023/08/Speaker-Header-Graphic-1.png https://www.integralmolecular.com/wp-content/uploads/2023/08/Speaker-Header-Graphic-1.png https://www.integralmolecular.com/reagents-evaluate-influenza-vaccine-efficacy/ 2025-04-28T18:50:08+00:00 https://www.integralmolecular.com/wp-content/uploads/2023/05/virology-logo2-color.jpg https://www.integralmolecular.com/integral-molecular-partnership-context-therapeutics-nominates-ctim-76-bispecific-antibody-candidate-to-develop-treatment-for-claudin-6-positive-solid-tumors/ 2025-04-28T18:50:25+00:00 https://www.integralmolecular.com/integral-molecular-launches-new-product-lines-of-safe-reporter-viruses-for-vaccine-development-and-pandemic-preparedness/ 2025-04-28T18:50:46+00:00 https://www.integralmolecular.com/integral-molecular-launches-paratope-plus/ 2025-05-28T18:42:17+00:00 https://www.integralmolecular.com/wp-content/uploads/2025/03/News-Page-Featured-Images.png https://www.integralmolecular.com/integral-molecular-named-top-workplace-by-philadelphia-inquirer/ 2025-06-04T15:17:17+00:00 https://www.integralmolecular.com/wp-content/uploads/2025/05/News-Page-Featured-Images-3.png https://www.integralmolecular.com/integral-molecular-achieves-iso-9001-certification-for-virology-critical-reagents/ 2025-06-04T17:36:04+00:00 https://www.integralmolecular.com/wp-content/uploads/2024/06/P1000051-scaled.jpg https://www.integralmolecular.com/one-third-of-antibody-drugs-are-nonspecific/ 2025-06-04T17:39:36+00:00 https://www.integralmolecular.com/wp-content/uploads/2024/09/Integral-Molecular-May-2024-72-scaled.jpg https://www.integralmolecular.com/wp-content/uploads/2024/09/MPA-presss-release-9.10.24.png https://www.integralmolecular.com/integral-molecular-unveils-trispecific-molecules/ 2025-06-04T18:20:40+00:00 https://www.integralmolecular.com/wp-content/uploads/2023/11/Integral-Molecular-May-2024-76-scaled.jpg https://www.integralmolecular.com/integral-molecular-mpa-iso-9001-certification/ 2025-06-04T18:30:53+00:00 https://www.integralmolecular.com/wp-content/uploads/2024/03/Integral-Molecular-May-2024-51-scaled.jpg https://www.integralmolecular.com/integral-molecular-out-licenses-first-in-class-antibody-panel-targeting-slc2a4/ 2025-06-17T12:00:49+00:00 https://www.integralmolecular.com/wp-content/uploads/2025/06/Untitled-design-2025-06-16T132853.072.png https://www.integralmolecular.com/integral-molecular-launches-ready-reporter-virus-kits/ 2025-10-14T11:55:31+00:00 https://www.integralmolecular.com/wp-content/uploads/2025/10/Adobe-Express-file.jpg https://www.integralmolecular.com/wp-content/uploads/2025/10/INTG_RRV-Assay-for-Same-Day-Neutralization.png https://www.integralmolecular.com/webinar-presented-by-integral-molecular-and-ipwatchdog-allowed-claims-through-cdr-scanning/ 2026-03-10T20:32:48+00:00 https://www.integralmolecular.com/wp-content/uploads/2026/02/Webinar-Pop-up-template-14.png https://www.integralmolecular.com/wp-content/uploads/2026/02/Webinar-Pop-up-template-14.png https://www.integralmolecular.com/integral-moleculars-membrane-proteome-array-nears-fda-qualification-as-a-drug-development-tool/ 2026-03-13T14:17:07+00:00 https://www.integralmolecular.com/wp-content/uploads/2025/10/image-4.jpg https://www.integralmolecular.com/webinar-presented-by-integral-molecular-and-fierce-biotech-best-practices-for-antibody-specificity-testing/ 2026-03-13T14:17:19+00:00 https://www.integralmolecular.com/wp-content/uploads/2025/04/MPA-Fierce-Webinar-2025-Email.jpg https://www.integralmolecular.com/wp-content/uploads/2025/04/MPA-Fierce-Webinar-2025-Email.jpg https://www.integralmolecular.com/fda-accepts-membrane-proteome-array-qualification-plan/ 2026-03-13T14:17:33+00:00 https://www.integralmolecular.com/wp-content/uploads/2025/02/Integral-Molecular-May-2024-31-scaled.jpg https://www.integralmolecular.com/integral-molecular-appoints-cheryl-paes-as-vice-president-of-commercial-strategy/ 2026-03-23T12:00:39+00:00 https://www.integralmolecular.com/wp-content/uploads/2026/03/Cheryl-e1774024253639.png https://www.integralmolecular.com/follow-our-ddt-qualification-journey/ 2026-03-30T13:37:41+00:00 https://www.integralmolecular.com/wp-content/uploads/2026/03/1-1_people-in-lab_featured-300x224-1.jpg https://www.integralmolecular.com/wp-content/uploads/2026/03/1-1_people-in-lab_featured-300x224-1.jpg https://www.integralmolecular.com/uspto-allows-antibody-genus-claims-in-patent-enabled-by-paratope-plus/ 2026-04-21T12:00:32+00:00 https://www.integralmolecular.com/wp-content/uploads/2026/04/antibody-variants.png https://www.integralmolecular.com/are-tissue-cross-reactivity-studies-sufficient-for-biotherapeutic-specificity-testing/ 2026-05-01T16:39:21+00:00 https://www.integralmolecular.com/wp-content/uploads/2026/03/3-1_TCR-study.png https://www.integralmolecular.com/wp-content/uploads/2026/03/3-1_TCR-study.png https://www.integralmolecular.com/wp-content/uploads/2026/03/3-2_TCR-survey_featured.png https://www.integralmolecular.com/how-is-the-mpa-being-qualified-by-the-fda/ 2026-05-01T16:54:46+00:00 https://www.integralmolecular.com/wp-content/uploads/2026/05/Featured-Image-Resizing.png https://www.integralmolecular.com/wp-content/uploads/2026/03/4-1_MPA-vs-TCR-table-scaled.png https://www.integralmolecular.com/wp-content/uploads/2026/03/4-2-ISTAND-progress_featured-sm.png https://www.integralmolecular.com/what-tools-are-available-for-specificity-testing-during-drug-development/ 2026-05-26T20:38:15+00:00 https://www.integralmolecular.com/wp-content/uploads/2026/03/2-1_1-in-3-are-polyspecific-1.png https://www.integralmolecular.com/wp-content/uploads/2026/03/2-1_1-in-3-are-polyspecific-1.png https://www.integralmolecular.com/wp-content/uploads/2026/03/2-2_CBPA-and-TCR-data.png https://www.integralmolecular.com/wp-content/uploads/2026/03/2-3_FDA-guidance-quotes_featured.png https://www.integralmolecular.com/1-in-3-antibody-drug-candidates/ 2026-06-22T13:09:28+00:00 https://www.integralmolecular.com/wp-content/uploads/2026/06/1.png https://www.integralmolecular.com/wp-content/uploads/2026/05/5-1_1-in-3_data-1.jpg https://www.integralmolecular.com/wp-content/uploads/2026/05/5-2_clinical-mabs_table-1.png https://www.integralmolecular.com/wp-content/uploads/2026/05/5-3_off-target_epitope-1.png https://www.integralmolecular.com/wp-content/uploads/2026/05/4-2-ISTAND-progress_featured-sm-resized.png https://www.integralmolecular.com/the-consequences-of-off-target-binding-are-real-so-are-the-solutions/ 2026-06-22T13:10:09+00:00 https://www.integralmolecular.com/wp-content/uploads/2026/06/2.png https://www.integralmolecular.com/wp-content/uploads/2026/06/6-1_camrelizumab-cs_featured.png https://www.integralmolecular.com/wp-content/uploads/2026/06/6-2_EBA-steps.png https://www.integralmolecular.com/integral-molecular-earns-back-to-back-top-workplace-honors-from-the-philadelphia-inquirer/ 2026-06-22T13:11:28+00:00 https://www.integralmolecular.com/wp-content/uploads/2026/06/Untitled-design-2026-06-22T091108.436.png https://www.integralmolecular.com/webinar-presented-by-integral-molecular-and-antibody-society-100-undruggable-targets-unlocked-through-parallel-mab-engineering/ 2026-06-29T14:30:26+00:00 https://www.integralmolecular.com/wp-content/uploads/2026/05/Reg-Landing-Page-Banner-Antibody-Soc-2026.png https://www.integralmolecular.com/wp-content/uploads/2026/05/Reg-Landing-Page-Banner-Antibody-Soc-2026.png